88 related articles for article (PubMed ID: 15025791)
1. Cetuximab targeted therapy: a new treatment paradigm for advanced colorectal cancer.
Chu E
Clin Colorectal Cancer; 2004 Feb; 3(4):205. PubMed ID: 15025791
[No Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
Venook AP
Cancer; 2005 Jun; 103(12):2435-46. PubMed ID: 15880563
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
4. The role of cetuximab in the treatment of metastatic colorectal cancer.
Holubec L; Liska V; Matejka VM; Fiala O; Dreslerova J; Mrazkova P; Treska V; Finek J
Anticancer Res; 2012 Sep; 32(9):4007-11. PubMed ID: 22993351
[TBL] [Abstract][Full Text] [Related]
5. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer.
Van Cutsem E
Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643
[TBL] [Abstract][Full Text] [Related]
6. Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversies.
Italiano A
Oncology; 2006; 70(3):161-7. PubMed ID: 16675911
[TBL] [Abstract][Full Text] [Related]
7. Cetuximab: from biology to the care of colorectal cancer patients.
Vincenzi B; Santini D; Tonini G
Future Oncol; 2007 Oct; 3(5):497-9. PubMed ID: 17927513
[No Abstract] [Full Text] [Related]
8. Molecular mechanisms and targeting of colorectal cancer.
Vanhoefer U
Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
[TBL] [Abstract][Full Text] [Related]
9. [Some problems facing the molecular targeting therapy for colorectal cancer].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):321-3. PubMed ID: 19799077
[No Abstract] [Full Text] [Related]
10. Response to reintroduction of cetuximab in 5 patients with advanced, chemotherapy-resistant, colorectal cancer without progressive disease following first-line therapy with a cetuximab-containing regimen.
Kaechele V; von Wichert G; Adler G; Seufferlein T
Oncology; 2008; 74(3-4):123-6. PubMed ID: 18708729
[TBL] [Abstract][Full Text] [Related]
11. Cetuximab.
Graham J; Muhsin M; Kirkpatrick P
Nat Rev Drug Discov; 2004 Jul; 3(7):549-50. PubMed ID: 15272498
[No Abstract] [Full Text] [Related]
12. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
13. Cetuximab-based therapy vs noncetuximab therapy in advanced or metastatic colorectal cancer: a meta-analysis of seven randomized controlled trials.
Liu L; Cao Y; Tan A; Liao C; Mo Z; Gao F
Colorectal Dis; 2010 May; 12(5):399-406. PubMed ID: 19508512
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for colorectal cancer.
Hwang J; Marshall JL
Curr Opin Investig Drugs; 2006 Dec; 7(12):1062-6. PubMed ID: 17209523
[TBL] [Abstract][Full Text] [Related]
15. Current issues in the targeted therapy of advanced colorectal cancer.
Knijn N; Tol J; Punt CJ
Discov Med; 2010 Apr; 9(47):328-36. PubMed ID: 20423677
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab for colorectal cancer.
Fraggetta F; Pelosi G
N Engl J Med; 2008 Mar; 358(11):1196; author reply 1196-7. PubMed ID: 18340663
[No Abstract] [Full Text] [Related]
17. Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?
Hoff PM; Ellis LM; Abbruzzese JL
Oncology (Williston Park); 2004 May; 18(6):736-41; discussion 742, 745-6. PubMed ID: 15214593
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness to cetuximab without mutations in EGFR.
Tsuchihashi Z; Khambata-Ford S; Hanna N; Jänne PA
N Engl J Med; 2005 Jul; 353(2):208-9. PubMed ID: 16014894
[No Abstract] [Full Text] [Related]
19. Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
Tonra JR; Corcoran E; Deevi DS; Steiner P; Kearney J; Li H; Ludwig DL; Zhu Z; Witte L; Surguladze D; Hicklin DJ
Anticancer Res; 2009 Jun; 29(6):1999-2007. PubMed ID: 19528458
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in the treatment of colorectal cancer.
Veronese ML; O'Dwyer PJ
Eur J Cancer; 2004 Jun; 40(9):1292-301. PubMed ID: 15177487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
